InsiderTrades

Form 4 for BIOA BioAge Labs, Inc.

Accepted 2026-02-03 00:00:00 ET · period of report 2026-02-02 · accession 0001210905-26-000005 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-02-03 2026-02-02 BIOA RUBIN PAUL D Chief Medical Off S - Sale+OE $18.75 -7,433 0 -100% -$139.4K
DM 2026-02-03 2026-02-02 BIOA RUBIN PAUL D Chief Medical Off M - OptEx $4.77 +7,433 5,433 New +$35.5K
DM 2026-02-03 2026-02-02 BIOA RUBIN PAUL D Chief Medical Off M - OptEx $0.00 -7,433 5,383 -58% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-02-02 S D 7,433 $18.75 0 D — —
2 Common Common Stock 2026-02-02 M A 2,000 $6.57 7,433 D — —
3 Common Common Stock 2026-02-02 M A 5,433 $4.11 5,433 D — —
4 Derivative Stock Option (Right to Buy) 2026-02-02 M D 5,433 $0.00 10,870 D $4.11 · — to 2030-06-30 5,433 Common Stock (F2) This option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on May 11, 2024.
5 Derivative Stock Option (Right to Buy) 2026-02-02 M D 2,000 $0.00 5,383 D $6.57 · — to 2032-05-28 2,000 Common Stock (F3) The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on April 1, 2022, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.